Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Prossimo Advisors LLC

Prossimo Advisors LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 447 shares of the medical equipment provider’s stock after selling 42 shares during the quarter. Prossimo Advisors LLC’s holdings in Intuitive Surgical were worth $233,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of ISRG. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $601.17 on Wednesday. The company has a market capitalization of $214.12 billion, a P/E ratio of 93.79, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business has a 50 day moving average price of $561.88 and a 200 day moving average price of $522.27.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. UBS Group raised their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Barclays upped their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Truist Financial boosted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.